Oidtman R, Meleleo G, Sharomi O, Matthews I, Ntais D, Nachbar R
    
    
    Infect Dis Ther. 2025; .
  
  
    PMID: 39930280
    
    
          DOI: 10.1007/s40121-025-01111-8.
      
 
                                  
  
    Oliveira G, Rivera J, Rodrigues T, Carneiro G, Ribeiro O, Miyaji E
    
    
    Immun Inflamm Dis. 2024; 12(12):e70062.
  
  
    PMID: 39641265
    
          PMC: 11621863.
    
          DOI: 10.1002/iid3.70062.
      
 
                                  
  
    Vasconcelos T, Rodrigues L, Krul D, Barbosa S, Siqueira A, Almeida S
    
    
    Front Microbiol. 2024; 15:1497377.
  
  
    PMID: 39640858
    
          PMC: 11619633.
    
          DOI: 10.3389/fmicb.2024.1497377.
      
 
                                  
  
    Gomes-Silva J, Pinho M, Friaes A, Ramirez M, Melo-Cristino J, Silva-Costa C
    
    
    Pneumonia (Nathan). 2024; 16(1):26.
  
  
    PMID: 39582053
    
          PMC: 11587768.
    
          DOI: 10.1186/s41479-024-00151-x.
      
 
                                  
  
    Kawaguchiya M, Urushibara N, Aung M, Ohashi N, Tsutida S, Kurashita K
    
    
    New Microbes New Infect. 2024; 62:101513.
  
  
    PMID: 39507501
    
          PMC: 11539348.
    
          DOI: 10.1016/j.nmni.2024.101513.
      
 
                              
              
                              
                                      
  Pneumococcal serotype prevalence and antibiotic resistance in children in South and Southeast Asia, 2012-2024.
  
    Lin T, Chiu C, Woo P, Razak Muttalif A, Dhar R, Choon Kit L
    
    
    Hum Vaccin Immunother. 2024; 20(1):2417554.
  
  
    PMID: 39478351
    
          PMC: 11533800.
    
          DOI: 10.1080/21645515.2024.2417554.
      
 
                                          
                                                          
  Pneumococcal Vaccine Breakthrough and Failure in Infants and Children: A Narrative Review.
  
    Feemster K, Weaver J, Buchwald U, Banniettis N, Cox K, McIntosh E
    
    
    Vaccines (Basel). 2023; 11(12).
  
  
    PMID: 38140155
    
          PMC: 10747311.
    
          DOI: 10.3390/vaccines11121750.
      
 
                                          
                                                          
  Changes in Invasive Pneumococcal Disease in the Paediatric Population in the Second COVID-19 Pandemic Year.
  
    Izquierdo C, Ciruela P, Soldevila N, Garcia-Garcia J, Gonzalez-Peris S, Diaz-Conradi A
    
    
    Vaccines (Basel). 2023; 11(10).
  
  
    PMID: 37896951
    
          PMC: 10611414.
    
          DOI: 10.3390/vaccines11101548.
      
 
                                          
                                                          
  Emerging vaccine strategies against the incessant pneumococcal disease.
  
    Duke J, Avci F
    
    
    NPJ Vaccines. 2023; 8(1):122.
  
  
    PMID: 37591986
    
          PMC: 10435554.
    
          DOI: 10.1038/s41541-023-00715-w.
      
 
                                          
                                                          
  Magnetic bead-based separation of pneumococcal serotypes.
  
    York A, Huynh E, Mbodj S, Yolda-Carr D, Hislop M, Echlin H
    
    
    Cell Rep Methods. 2023; 3(2):100410.
  
  
    PMID: 36936076
    
          PMC: 10014298.
    
          DOI: 10.1016/j.crmeth.2023.100410.
      
 
                                          
                                                          
  Continued Vaccine Breakthrough Cases of Serotype 3 Complicated Pneumonia in Vaccinated Children, Portugal (2016-2019).
  
    Silva-Costa C, Gomes-Silva J, Pinho M, Friaes A, Ramirez M, Melo-Cristino J
    
    
    Microbiol Spectr. 2022; 10(4):e0107722.
  
  
    PMID: 35862941
    
          PMC: 9431508.
    
          DOI: 10.1128/spectrum.01077-22.
      
 
                                          
                                                          
  Enhancing efficacy of existing antibacterials against selected multiple drug resistant bacteria using cinnamic acid-coated magnetic iron oxide and mesoporous silica nanoparticles.
  
    Akbar N, Kawish M, Jabri T, Khan N, Raza Shah M, Siddiqui R
    
    
    Pathog Glob Health. 2021; 116(7):438-454.
  
  
    PMID: 34937524
    
          PMC: 9518276.
    
          DOI: 10.1080/20477724.2021.2014235.
      
 
                                          
                                                          
  Serotypes and Clonal Composition of Streptococcus pneumoniae Isolates Causing IPD in Children and Adults in Catalonia before 2013 to 2015 and after 2017 to 2019 Systematic Introduction of PCV13.
  
    Redin A, Ciruela P, de Sevilla M, Gomez-Bertomeu F, Gonzalez-Peris S, Benitez M
    
    
    Microbiol Spectr. 2021; 9(3):e0115021.
  
  
    PMID: 34878302
    
          PMC: 8653838.
    
          DOI: 10.1128/Spectrum.01150-21.
      
 
                                          
                                                          
  Pediatric Invasive Pneumococcal Disease Three Years after PCV13 Introduction in the National Immunization Plan-The Continued Importance of Serotype 3.
  
    Silva-Costa C, Gomes-Silva J, Prados L, Ramirez M, Melo-Cristino J, The Portuguese Group For The Study Of Streptococcal Infections 
    
    
    Microorganisms. 2021; 9(7).
  
  
    PMID: 34361864
    
          PMC: 8304318.
    
          DOI: 10.3390/microorganisms9071428.
      
 
                                          
                                                          
  Streptococcus pneumoniae serotype 3 genotypes in invasive isolates from Colombia.
  
    Alarcon Z, Duarte C, Sanabria O, Moreno J
    
    
    Biomedica. 2021; 41(2):338-346.
  
  
    PMID: 34214273
    
          PMC: 8387017.
    
          DOI: 10.7705/biomedica.5407.
      
 
                                          
                                                          
  A Structural Model for the Ligand Binding of Pneumococcal Serotype 3 Capsular Polysaccharide-Specific Protective Antibodies.
  
    Ozdilek A, Huang J, Babb R, Paschall A, Middleton D, Duke J
    
    
    mBio. 2021; 12(3):e0080021.
  
  
    PMID: 34061603
    
          PMC: 8262990.
    
          DOI: 10.1128/mBio.00800-21.
      
 
                                          
                                                          
  Properties of Mucoid Serotype 3  From Children in China.
  
    Yang Y, Hua C, Fang C, Xie Y, Li W, Fu Y
    
    
    Front Cell Infect Microbiol. 2021; 11:648040.
  
  
    PMID: 33842394
    
          PMC: 8024565.
    
          DOI: 10.3389/fcimb.2021.648040.
      
 
                                          
                                                          
  Multi-Valent Protein Hybrid Pneumococcal Vaccines: A Strategy for the Next Generation of Vaccines.
  
    Scott N, Mann B, Tuomanen E, Orihuela C
    
    
    Vaccines (Basel). 2021; 9(3).
  
  
    PMID: 33801372
    
          PMC: 8002124.
    
          DOI: 10.3390/vaccines9030209.
      
 
                                          
                                                          
  Sugar-Coated Killer: Serotype 3 Pneumococcal Disease.
  
    Luck J, Tettelin H, Orihuela C
    
    
    Front Cell Infect Microbiol. 2021; 10:613287.
  
  
    PMID: 33425786
    
          PMC: 7786310.
    
          DOI: 10.3389/fcimb.2020.613287.
      
 
                                          
                                                          
  The direct effect of pneumococcal conjugate vaccines on invasive pneumococcal disease in children in the Latin American and Caribbean region (SIREVA 2006-17): a multicentre, retrospective observational study.
  
    Agudelo C, Castaneda-Orjuela C, Brandileone M, Echaniz-Aviles G, Almeida S, Carnalla-Barajas M
    
    
    Lancet Infect Dis. 2020; 21(3):405-417.
  
  
    PMID: 32986996
    
          PMC: 9759960.
    
          DOI: 10.1016/S1473-3099(20)30489-8.